Trial Profile
High-dose 131I-MIBG Treatment Incorporated Into Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With High-risk Neuroblastoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary) ; Carboplatin; Cyclophosphamide; Etoposide; Interleukin-2; Melphalan; Thiotepa; Tretinoin
- Indications Neuroblastoma
- Focus Therapeutic Use
- 01 Mar 2017 New trial record